Prices delayed by at least 15 minutes | Print


Elekta AB ser. B (EKTA B)

Sell: 74.4 SEK|Buy: 74.5 SEK|Change: 0.55 (-0.73%)

Open 

74.4 SEK


Previous close 

75 SEK


Trade high 

74.9 SEK


Volume 

1,265,198


Year high 

90.42 SEK


Year low 

70.00 SEK


Dividend yield 

3.2%


Market capitalisation 

28.45 bn SEK


P/E ratio 

20.00


ISIN 

SE0000163628


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 19/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Elekta AB ser. B- 0.73
More...

Company profile

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,000 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and the Asia-Pacific contributing the remainder.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.